TransThera Biosciences Completes Series D+ Financing Round
China’s Nanjing TransThera Sciences (Nanjing), Inc. has announced the completion of a Series D+ financing...
China’s Nanjing TransThera Sciences (Nanjing), Inc. has announced the completion of a Series D+ financing...
China-based Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607) has announced receiving clinical clearance from the...
China-based Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521) plans to raise RMB 1.56 billion (USD...
Chinese firm Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) has announced a strategic partnership agreement...
February 23 will mark the oral hearing phase for the patent challenge case brought by...
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced the completion of all-patient enrollment and...
China-based Sinovac Biotech Ltd (NASDAQ: SVA) has announced obtaining market approval from the Egyptian Drug...
China-based urogenital cancer specialist Jiangsu Yahong Meditech Co., Ltd (Asieris, SHA: 688176) has announced that...
Merck KGaA (ETR: MRK), a leading German pharmaceutical company, has struck a partnership with the...
China-based AI-powered drug discovery firm Insilico Medicine has announced that its ISM3312, an oral COVID-19...
Meihua International Medical Technologies Co., Ltd (NASDAQ: MHUA), a specialist in Chinese medical consumables, has...
Kactus Biosystems, a Shanghai-based firm specializing in target proteins and raw enzymes, has announced a...
The Center for Drug Evaluation (CDE) has released the 67th batch of chemical generic reference...
The Center for Drug Evaluation (CDE) has released the “Technical Guidelines for Pharmaceutical Research of...
Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) has announced significant progress in the Phase...
US-based Abbott (NYSE: ABT) has entered into a strategic partnership with Sinopharm’s China National Medical...
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd (SHE: 002793), a leading China-based pharmaceutical company, has...
China-based Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607) has announced that the National Medical Products...
We-Linking, a developer of fully implantable wireless brain-computer interface systems based in Shenzhen, has reportedly...
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) has entered into a collaboration agreement with compatriot...